PSWC Young Scientist Satellite Conference 2017
Improving your skills for research in drug discovery, drug development and clinical usage
Track A: Fundamental & translational sciences and targeting sciencesTrack B: Drug delivery formulation, manufacturing sciencesTrack C: Regulatory science and science-based practice |
YSC Final Programme |
|
Friday 19 May |
|||
|
12:00-14:00 |
Arrival and Registration |
||
|
14:00 - 16:00
|
Plenary Opening Ceremony Lecture hall B:B8 14:00 - 14:40 Welcome and opening of conference 14:40 – 15:20 Plenary lecture 15:20 – 16:00 Plenary lecture |
||
|
18:00– 21:00 |
Conference dinner and party at Norrlands student nation |
||
|
Saturday 20 May |
|||
|
08:30 - 09:00 |
Poster mounting |
||
|
|
Track A |
Track B |
Track C |
|
09:00– 09:45 |
Keynote Room B:B22 Rada Savic, University of California San Francisco Use of pharmacometrics and data science to combat global health problems |
Keynote Room B:B41 Jan Kihlberg, Uppsala University Drug discovery beyond the rule of 5 - How to design cell permeable ligands for difficult targets. |
Keynote Room B:B42 Staffan Folestad, AstraZeneca R&D Provision of innovative medicines for the individual – Need for patient centric engineering in global health |
|
10:00– 10:45 |
Workshop sessions |
||
|
WS1 – part 1 Excellence in science Elizabeth de Lange, Leiden Academic Centre for Drug Research, the Netherlands Room A1:104b |
WS2 - part 1 Grant application Krister Halldin, Uppsala University, Sweden Room A1:112b |
WS3 - part 1 Patenting Olivia Tolan and Pontus Skråmstadius, UU Innovation, Uppsala University, Sweden Room A7:108 |
|
|
WS4 - part 1 Communicate science Stacey May, American Association for Pharmaceutical Scientists, USA Room A7:114 |
WS5 - part 1 Entrepreneurship/Pitch your idea Moa Fransson, UU Innovation, Uppsala University, Sweden Room A7:103 |
WS6 - part 1 Regulatory framework Pieter Stolk, Utrecht University, the Netherlands Room A2:108a |
|
|
|
WS7 - part 1 Pedagogical skills Don Mager, University of Buffalo, USA Room A2:122a |
|
|
|
10:45– 11:15 |
Fika break |
||
|
11:15– 12:00 |
Workshop sessions |
||
|
WS1 – part 2 Excellence in science Elizabeth de Lange, Leiden Academic Centre for Drug Research, the Netherlands Room A1:104b |
WS2 – part 2 Grant application Krister Halldin, Uppsala University, Sweden Room A1:112b |
WS3 – part 2 Patenting Olivia Tolan and Pontus Skråmstadius, UU Innovation, Uppsala University, Sweden Room A7:108 |
|
|
WS4 – part 2 Communicate science Stacey May,American Association for Pharmaceutical Scientists, USA Room A7:114 |
WS5 – part 2 Entrepreneurship/Pitch your idea Moa Fransson, UU Innovation, Uppsala University, Sweden Room A7:103 |
WS6 – part 2 Regulatory framework Pieter Stolk, Utrecht University, the Netherlands Room A2:108a |
|
|
|
WS7 – part 2 Pedagogical skills Don Mager, University of Buffalo, USA Room A2:122a |
|
|
|
12:00– 14:00 |
Lunch and poster viewing 13:30 - 14:00 Room B:B42 Award ceremony for, and lecture by, the recipient Dr. Shalini Singh |
||
|
14:00– 15:30 |
Short communication A1: Transporters and permeability Room B:B22 Chair: Elizabeth de Lange, Leiden University Co-chair: Amal Kamal Abdel-Aziz, Ain Shams University |
Short communication B1: Modeling and synthesis Room B:B41 Chair: Anja Sandström, Uppsala University Co-chair: Irina Elena Antonescu, University of Southern Denmark |
Short communication C1: Regulatory, practice and manufacturing Room B:B42 Chair: Bente Steffansen, University of Southern Denmark Co-chair: Maria Badal Tejedor,Research Insitutes of Sweden |
|
15:30– 16:00 |
Fika break |
||
|
16:00– 17:30 |
Short communication A2: Intestinal absorption and antibiotic drug delivery Room B:B22 Chair: Pieter Stolk, Utrecht University Co-chair: Amani Al-Hayali, Luleå University of Technology |
Short communication B2: Permeability and cells Room B:B41 Chair: Chamari Hettiarachchi, University of Colombo Co-chair: Diego Romano Perinelli, University of Camerino |
Short communication A3: Drug delivery systems and pharmacokinetics Room B:B42 Chair: Anne Filppula, Uppsala University Co-chair: Javier Morales, University of Chile |
|
Sunday 21 May |
|||
|
|
Track A Fundamental & translational sciences, and targeting sciences |
Track B Drug delivery and formulation, manufacturing sciences |
Track C Regulatory sciences, and science-based practice |
|
09:00– 10:30 |
Plenary session Lecture Hall B:B8 09:00 - 09:45 Plenary lecture 09:45 - 10:30 Plenary lecture |
||
|
10:30– 11:30 |
Fika break and poster viewing |
||
|
11:30– 12:45 |
Plenary Closing Ceremony Lecture Hall B:B8 11:30 – 12:15 Plenary lecture 12:15 – 12:45 Award ceremony and closing remarks |
||
|
13:30 |
Bus departures to Stockholm (buses will be arranged for all participants) Lunch |
||
Short Communication Sessions
|
Short communication session |
Abstract No |
Abstract title |
Presenting Author |
|
Drug delivery & targeting sciences and formulation & manufacturing sciences |
|||
|
A1: Transporters and permeability |
1014 |
Transporter protein expression and localization in the human retinal pigment epithelium cell models |
Laura Pelkonen, University of Eastern Finland, Finland |
|
1015 |
How is mucus influencing on drug permeability in the PVPA? |
Margherita Falavigna, University of Tromsø, Norway |
|
|
1091 |
Effect of amino acid-based surfactants on Caco-2 cell permeability of macromolecular drugs |
Diego Romano Perinelli, University of Camerino, Italy |
|
|
1027 |
The use of Caco-2 cells to evaluate drug absorption from lipid-based formulations |
Janneke Keemink, Uppsala University, Sweden |
|
|
|
|
|
|
|
Drug delivery & targeting sciences and formulation & manufacturing sciences |
|||
|
A2: Intestinal absorption and antibiotic drug delivery |
1085 |
Understanding the link between composition, structure formation and absorption of milk during digestion |
Anna C. Pham, Monash Institute of Pharmaceutical Sciences, Australia |
|
1057 |
The effect of sparkling water on intraluminal formulation behaviour and systemic drug performance in man |
Jens Van Den Abeele, KU Leuven, Belgium |
|
|
1065 |
Examining the interaction of mesoporous silica particles with lipid digestion components |
Kellie May, Monash Institute of Pharmaceutical Sciences, Australia |
|
|
1046 |
In vitro lipolysis of drug loaded lipid-based formulations with solid-state characterization of drug precipitate |
Linda C. Alskär, Uppsala University, Sweden |
|
|
|
|
|
|
|
Drug delivery & targeting sciences and formulation & manufacturing sciences |
|||
|
A3: Drug delivery systems and pharmacokinetics |
1043 |
Synthesis and characterization of PEGylated polyethyleneimine-entrapped gold nanoparticles by self-reduction |
Shayesteh Amin, Shiraz University of Medical Sciences, Iran |
|
1028 |
In Vitro Cytotoxicity and In Vivo Biodistribution of Simvastatin-loaded Lecithin/Chitosan Nanoparticles: Nasal Region as an Appealing Route for Brain Delivery |
Adryana Clementino, National Council for Scienctific and Technological Development, Brazil |
|
|
1093 |
Effects of silymarin on the pharmacokinetics of carbamazepine, oxcarbazepine, phenytoin and their main metabolites in rats |
Ana Filipa Ferreira, University of Beira Interior, Portugal |
|
|
1023 |
Pharmacokinetic evaluation of doxorubicin containing lipiodol-based emulsion and drug-eluting beads used in the treatment of intermediate hepatocellular carcinoma |
Ilse Dubbelboer, Uppsala University, Sweden |
|
|
|
|
|
|
|
Drug design, fundamental & translational sciences |
|||
|
B1: Modeling and synthesis |
1011 |
Design, Synthesis and Testing of novel small molecule inhibitors of S-phase Kinase-Associated Protein 2 |
Ran Liu, University of Sydney, Australia |
|
1089 |
Engineering of KR-12 derived from human host defence peptide LL-37 into stable, selective and potent antimicrobial drug lead |
Taj Muhammad, Uppsala University, Sweden |
|
|
1073 |
A semi-mechanistic PK/PD model to elucidate levofloxacin-induced killing and resistance development of Escherichia coli |
Eva Goebgen, Institute of Pharmacy Germany |
|
|
1069 |
Evaluating predictors of paclitaxel-associated peripheral neuropathy: a pharmacodynamic modelling approach |
Francis Williams Ojara, Freie Universitaet Berlin, Germany |
|
|
|
|
|
|
|
Drug design, fundamental & translational sciences |
|||
|
B2: Permeability and cells |
1025 |
Measuring and modelling pH-profile of membrane permeability |
Mare Oja, University of Tartu, Estonia |
|
1038 |
Influence of lipophilicity and hydrogen bond formation on passive diffusion of small-molecule drugs across hexadecane-based artificial cell membranes |
Ursula Thormann, Uppsala University, Sweden |
|
|
1062 |
Factors affecting intestinal drug permeation in-vitro: rat intestinal tissue vs. artificial membrane |
Danny Riethorst, KU Leuven, Belgium |
|
|
1033 |
Attach or perish: culture morphology and causal factors for variable attachment properties of cryopreserved human hepatocytes |
Magnus Ölander, Uppsala University, Sweden |
|
|
|
No reserve. |
|
|
|
Regulatory sciences and science based practice |
|||
|
C1: Regulatory, practice and manufacturing |
1080 |
Pharmacists’ activities to minimise medication waste: an international survey |
Charlotte Bekker, Utrecht University, Netherlands |
|
1086 |
Digital Patient Support Tools for Improved Cardiovascular Disease Rehabilitatio |
Alexander Mammoo, AstraZeneca, Sweden |
|
|
1087 |
Impact of Different MIC Distribution in Determining Empirical Vancomycin Continuous Infusion Dosing in Critically Ill Population |
Eko Setiawan, University of Surabaya, Indonesia |
|
|
1070 |
Designing relevant test methods to characterise the disintegration properties of rapidly disintegrating tablets |
Charlotte Bain, AstraZeneca, United Kingdom |
|
|
|
|
|
|
